Literature DB >> 31445906

Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10.

Carlos R Hernandez-Castillo1, Rosalinda Diaz2, Israel Vaca-Palomares3, Diana L Torres2, Amanda Chirino2, Aurelio Campos-Romo4, Adriana Ochoa5, Astrid Rasmussen6, Juan Fernandez-Ruiz7.   

Abstract

INTRODUCTION: Spinocerebellar ataxia type 10 (SCA10) is a hereditary neurodegenerative disorder caused by repeat expansions in the ATXN10 gene. Patients present with cerebellar ataxia frequently accompanied by seizures. Even though loss of cerebellar Purkinje neurons has been described, its brain degeneration pattern is unknown. Our aim was to characterize the gray and white matter degeneration patterns in SCA10 patients and the association with clinical features.
METHODS: We enrolled 18 patients with molecular diagnosis of SCA10 and 18 healthy individuals matched for age and sex. All participants underwent brain MRI including high-resolution anatomical and diffusion images. Whole-brain Tract-Based Spatial Statistics (TBSS) and Voxel-Based Morphometry (VBM) were performed to identify white and grey matter degeneration respectively. A second analysis in the cerebellum identified the unbiased pattern of degeneration. Motor impairment was assessed using the SARA Scale.
RESULTS: TBSS analysis in the patient group revealed white matter atrophy exclusively in the cerebellum. VBM analysis showed extensive grey matter degeneration in the cerebellum, brainstem, thalamus, and putamen. Significant associations between cerebellar degeneration and SARA scores were found. Additionally, degeneration in thalamic GM and WM in the cerebellar lobule VI were significantly associated with the presence of seizures.
CONCLUSION: The results show that besides cerebellum and brainstem, brain degeneration in SCA10 includes predominantly the putamen and thalamus; involvement of the latter is strongly associated with seizures. Analysis of the unbiased degeneration pattern in the cerebellum suggests lobules VIIIb, IX, and X as the primary cerebellar targets of the disease, which expands to the anterior lobe in later stages.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebellum; SCA10; Seizures; Thalamus; Voxel based morphometry

Mesh:

Year:  2019        PMID: 31445906     DOI: 10.1016/j.parkreldis.2019.08.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Cells       Date:  2022-05-06       Impact factor: 7.666

2.  Cerebellar Abnormalities on Proton MR Spectroscopy and Imaging in Patients With Gluten Ataxia: A Pilot Study.

Authors:  Vishwa Rawat; Ritu Tyagi; Inder Singh; Prasenjit Das; Achal Kumar Srivastava; Govind K Makharia; Uma Sharma
Journal:  Front Hum Neurosci       Date:  2022-05-17       Impact factor: 3.473

Review 3.  Cerebellar Astrocytes: Much More Than Passive Bystanders In Ataxia Pathophysiology.

Authors:  Valentina Cerrato
Journal:  J Clin Med       Date:  2020-03-11       Impact factor: 4.241

4.  ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10.

Authors:  C Alejandra Morato Torres; Faria Zafar; Yu-Chih Tsai; Jocelyn Palafox Vazquez; Michael D Gallagher; Ian McLaughlin; Karl Hong; Jill Lai; Joyce Lee; Amanda Chirino-Perez; Angel Omar Romero-Molina; Francisco Torres; Juan Fernandez-Ruiz; Tetsuo Ashizawa; Janet Ziegle; Francisco Javier Jiménez Gil; Birgitt Schüle
Journal:  HGG Adv       Date:  2022-08-15

Review 5.  The genetic and molecular features of the intronic pentanucleotide repeat expansion in spinocerebellar ataxia type 10.

Authors:  Tatsuaki Kurosaki; Tetsuo Ashizawa
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

6.  Altered cerebral blood flow in patients with spinocerebellar degeneration.

Authors:  Bing Liu; Aocai Yang; Wenwen Gao; Yue Chen; Yige Wang; Xiuxiu Liu; Kuan Lv; Linwei Zhang; Guolin Ma
Journal:  Front Neurosci       Date:  2022-09-13       Impact factor: 5.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.